Abstract
RP-1776, a novel cyclic peptide, was isolated from the culture broth of Streptomyces sp. KY11784. RP-1776 selectively inhibited the binding of PDGF BB to the extracellular domain of the PDGF beta-receptor with an IC50 value of 11 +/- 6 microM. Detailed binding experiments suggested that RP-1776 directly interacts with PDGF BB. RP-1776 inhibited the phosphorylation of the PDGF beta-receptor induced by PDGF BB. These results suggested that RP-1776 antagonizes the signaling of PDGF BB probably through the inhibition of PDGF BB binding to the PDGF beta-receptor.
MeSH terms
-
Animals
-
Anti-Bacterial Agents / chemistry
-
Anti-Bacterial Agents / isolation & purification*
-
Anti-Bacterial Agents / pharmacology*
-
Becaplermin
-
CHO Cells
-
Cricetinae
-
Depsipeptides
-
Fermentation
-
Inhibitory Concentration 50
-
Magnetic Resonance Spectroscopy
-
Microbial Sensitivity Tests
-
Peptides, Cyclic / chemistry
-
Peptides, Cyclic / isolation & purification*
-
Peptides, Cyclic / pharmacology*
-
Phosphorylation / drug effects
-
Platelet-Derived Growth Factor / antagonists & inhibitors*
-
Platelet-Derived Growth Factor / metabolism
-
Protein Structure, Tertiary
-
Proto-Oncogene Proteins c-sis
-
Receptors, Platelet-Derived Growth Factor / metabolism*
-
Soil Microbiology
-
Streptomyces / chemistry*
-
Streptomyces / metabolism
Substances
-
Anti-Bacterial Agents
-
Depsipeptides
-
Peptides, Cyclic
-
Platelet-Derived Growth Factor
-
Proto-Oncogene Proteins c-sis
-
platelet-derived growth factor A
-
skyllamycins
-
Becaplermin
-
Receptors, Platelet-Derived Growth Factor